These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
905 related items for PubMed ID: 22300563
1. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ. Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):112-8. PubMed ID: 22300563 [Abstract] [Full Text] [Related]
2. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA. Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249 [Abstract] [Full Text] [Related]
3. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy. Geinitz H, Riegel MG, Thamm R, Astner ST, Lewerenz C, Zimmermann F, Molls M, Nieder C. Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1930-7. PubMed ID: 21514736 [Abstract] [Full Text] [Related]
4. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study. Wiegel T, Lohm G, Bottke D, Höcht S, Miller K, Siegmann A, Schostak M, Neumann K, Hinkelbein W. Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1009-16. PubMed ID: 18963539 [Abstract] [Full Text] [Related]
5. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy. King CR, Spiotto MT. Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):23-7. PubMed ID: 18207668 [Abstract] [Full Text] [Related]
6. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E. Cancer J Sci Am; 1997 May 01; 3(2):78-87. PubMed ID: 9099457 [Abstract] [Full Text] [Related]
7. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy. Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J. Int J Radiat Oncol Biol Phys; 2007 Apr 01; 67(5):1411-7. PubMed ID: 17275204 [Abstract] [Full Text] [Related]
8. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L. BJU Int; 2011 Jun 01; 107(11):1748-54. PubMed ID: 20883488 [Abstract] [Full Text] [Related]
13. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer. Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY. Int J Radiat Oncol Biol Phys; 2013 Oct 01; 87(2):275-81. PubMed ID: 23886418 [Abstract] [Full Text] [Related]
14. Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors. Brooks JP, Albert PS, Wilder RB, Gant DA, McLeod DG, Poggi MM. J Urol; 2005 Dec 01; 174(6):2204-8, discussion 2208. PubMed ID: 16280764 [Abstract] [Full Text] [Related]
15. [Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: comparisons among ASTRO and Phoenix biochemical failure definitions]. Quero L, Mongiat-Artus P, Ravery V, Hennequin V, Maylin C, Desgrandchamps F, Hennequin C. Cancer Radiother; 2009 Jul 01; 13(4):267-75. PubMed ID: 19446487 [Abstract] [Full Text] [Related]
16. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? King CR, Presti JC, Gill H, Brooks J, Hancock SL. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):341-7. PubMed ID: 15145146 [Abstract] [Full Text] [Related]
17. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Urology; 2004 Jul 01; 64(1):84-9. PubMed ID: 15245941 [Abstract] [Full Text] [Related]
18. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA. Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):448-53. PubMed ID: 15890586 [Abstract] [Full Text] [Related]
19. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D. Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):134-40. PubMed ID: 16111581 [Abstract] [Full Text] [Related]
20. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy. King CR, Presti JC, Brooks JD, Gill H, Spiotto MT. Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1472-7. PubMed ID: 17935902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]